Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells World Congress

Hakim Djaballah's Biography



Hakim Djaballah, CEO, Institute Pasteur - Korea

Dr. Djaballah has several years of industrial experience in early drug discovery gained over the years in pharma and biotech companies. He has extensive experiences in the areas of fluorescence technology, assay development, automation/robotics, HTS, compound & screening data management, software development & novel technologies. Dr Djaballah has been involved in developing and screening several targets in various therapeutic areas, including antibacterials, antivirals, antifungals, diabetes, CNS, cardiovascular, oncology & inflammation. He is currently the director of the high throughput drug screening core facility at Memorial Sloan Kettering Cancer Centre in New York. He obtained his BSc (Hons.) in biochemistry and biotechnology from the University of Birmingham, and his PhD in biochemistry from the University of Leicester, both in England.

Hakim Djaballah Image

High Content Assay Strategies to Screen iPS Cells with no Screenable Phenotype

Tuesday, 25 January 2011 at 09:30

Add to Calendar ▼2011-01-25 09:30:002011-01-25 10:30:00Europe/LondonHigh Content Assay Strategies to Screen iPS Cells with no Screenable PhenotypeStem Cells World Congress in San DiegoSan DiegoSELECTBIOenquiries@selectbiosciences.com

We have successfully implemented a novel assay strategy to screen iPS cells where there is no obvious phenotype that can be measured using conventional HTS detection methodologies. The assay was developed in 384-well plates and makes use of an unusual readout technology for HTS. The assay was validated in a pilot screen against a library of 6,000 compounds. I will present some data on this novel way to screen iPS cells and discuss its merits for drug discovery and geno-toxicity assessment.


Add to Calendar ▼2011-01-24 00:00:002011-01-25 00:00:00Europe/LondonStem Cells World CongressStem Cells World Congress in San DiegoSan DiegoSELECTBIOenquiries@selectbiosciences.com